95 related articles for article (PubMed ID: 9764295)
1. Cyclin D1 expression as a prognostic factor in advanced hypopharyngeal carcinoma.
Nishimura G; Tsukuda M; Zhou LX; Furukawa S; Baba Y
J Laryngol Otol; 1998 Jun; 112(6):552-5. PubMed ID: 9764295
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
3. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression is useful as a prognostic indicator for advanced esophageal carcinomas, but not for superficial tumors.
Toyoda H; Nakamura T; Shinoda M; Suzuki T; Hatooka S; Kobayashi S; Ohashi K; Seto M; Shiku H; Nakamura S
Dig Dis Sci; 2000 May; 45(5):864-9. PubMed ID: 10795746
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of cyclin D1 in renal cell carcinoma.
Lima MS; Pereira RA; Costa RS; Tucci S; Dantas M; Muglia VF; Ravinal RC; Barros-Silva GE
Int Urol Nephrol; 2014 May; 46(5):905-13. PubMed ID: 24242739
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.
Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS
Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.
Mylona E; Tzelepis K; Theohari I; Giannopoulou I; Papadimitriou C; Nakopoulou L
Histopathology; 2013 Feb; 62(3):472-80. PubMed ID: 23163571
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell-cycle regulator p27 is correlated to the prognosis and ER expression in breast carcinoma patients.
Nohara T; Ryo T; Iwamoto S; Gon G; Tanigawa N
Oncology; 2001; 60(1):94-100. PubMed ID: 11150915
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers for predicting prostate cancer stage and survival.
Dunsmuir WD; Gillett CE; Meyer LC; Young MP; Corbishley C; Eeles RA; Kirby RS
BJU Int; 2000 Nov; 86(7):869-78. PubMed ID: 11069416
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 and PSA act as good prognostic and clinicopathological indicators for breast cancer.
Holah NS; Hemida AS
J Immunoassay Immunochem; 2020; 41(1):28-44. PubMed ID: 31631753
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
Formentini A; Henne-Bruns D; Kornmann M
Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
[TBL] [Abstract][Full Text] [Related]
14. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
[TBL] [Abstract][Full Text] [Related]
15. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
Mielcarek-Kuchta D; Olofsson J; Golusinski W
Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy.
Abdelrahman AE; Fathy A; Elsebai EA; Nawar N; Etman WM
Ann Diagn Pathol; 2018 Aug; 35():27-37. PubMed ID: 30072015
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1, cyclin E, and p21 have no apparent prognostic value in anal carcinomas treated by radiotherapy with or without chemotherapy.
Allal AS; Gervaz P; Bründler MA
Br J Cancer; 2004 Oct; 91(7):1239-44. PubMed ID: 15292923
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between cyclin D1 and hypopharyngeal carcinoma].
Chen W; Wang T
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(6):250-2. PubMed ID: 16013506
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.
Barbieri F; Lorenzi P; Ragni N; Schettini G; Bruzzo C; Pedullà F; Alama A
Oncology; 2004; 66(4):310-5. PubMed ID: 15218299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
